Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biomarkers 2014

Biomarkers 2014

Date: Tuesday, 8 July 2014 - Wednesday, 9 July 2014
Location: Cambridge, UK

Keynote Speakers

Andreas Jeromin

Andreas Jeromin
President & Cso, Atlantic Biomarkers LLC

Declan Jones

Declan Jones
Neuroscience Therapeutic Area Lead, J&J London Innovation Centre

Thomas Joos

Thomas Joos
Deputy Managing Director, University of Tuebingen

Alain Van Gool

Alain Van Gool
Head of Biomarkers in Personalised Healthcare, TNO


SELECTBIO, working together with Andreas Jeromin are pleased to announce their joint collaboration: Biomarkers in CNS Drug Discovery and Development: From Discovery to Clinical Diagnostics.

This meeting will highlight current advances in the use of biomarkers in the context of CNS drug discovery and development and highlight strategies for their translation from discovery tolls to clinical diagnostics. This is embedded into the discussion of innovate technologies for biomarker development, their non-clinical use, clinical development and regulatory strategies and serve as a unique forum for networking, critical assessment based on presented case studies and panel discussions. It will bring together a group of international experts across academy and industry across a spectrum of CNS disorders, ranging from neurodegenerative, neuropsychiatric, neurodevelopmental to neurological disorders.

Agenda Topics

  • Biomarkers in Neurodegeneration (AD/PD)
  • Biomarkers in Neurological Diseases
  • Biomarkers in Neuropsychiatric Diseases
  • Biomarkers: Technical Considerations and Applications in Drug Development

Sponsorship and Exhibition Opportunities

Exhibition Team,
+44 (0) 1206 501654

Confirmed Speakers to date

John Allinson, Head of Biomarker Strategy, LGC Limited
Sabine Bahn, Professor, University of Cambridge
Paul Edison, Clinical Senior Lecturer, Imperial College London
Christian Foerch, Head of the Cerebrovascular Research Group at the Department of Neurology, Goeth University
Kim Henriksen, Head, Nordic Bioscience A/S
Brit Mollenhauer, Head of Clinical Research, Paracelsus-Elena-Klinik
Alan Palmer, CSO, MS Therapeutics
Ian Pike, Chief Operating Officer, Proteome Sciences Plc
Jill Richardson, Director, Neuroinflammation DPU, GlaxoSmithKline
Rachael Scahill, Senior Research Associate, Microscience Ltd
Martin Turner, Consultant Neurologist, Oxford University
Claude Wischik, Executive Chairman & Co Founder, TauRx Therapeutics Ltd

Exhibition Sponsors Media Sponsors Networking

Add to Calendar ▼2014-07-08 00:00:002014-07-09 00:00:00Europe/LondonBiomarkers 2014Biomarkers 2014 in Cambridge, UKCambridge,